Bill.com Holdings Inc vs BIO-TECHNE Corp — how do they compare? Bill.com Holdings Inc trades at $42.93 (market cap $4.27B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: BIO-TECHNE Corp is far larger — about 2.6× Bill.com Holdings Inc's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Bill.com Holdings Inc pays none. Which is the better fit depends on your goals.
| BILL | TECH | |
|---|---|---|
Market Cap | $4.27B | $11.12B |
Sector | Technology | Health |
52-Week High | $56.32 | $71.38 |
52-Week Low | $31.96 | $43.31 |
Enterprise Value | $3.98B | $11.20B |
Dividend Yield | — | 0.45% |
Trailing returns across standard periods
Bill.com Holdings Inc is a provider of cloud-based software that simplifies, digitizes, and automates financial operations for SMBs. Its artificial-intelligence enabled financial software platform used mostly to build connections between customers, suppliers, and clients. The company's platform generates and process invoices, streamline approvals, send and receive payments, sync with their accounting system, and manage their cash. The firm generates revenue through subscription and transaction fees.
Read more on BILL →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →